Jaakko Tuomilehto

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

Tiia Ngandu, Jenni Lehtisalo, Alina Solomon et al. · The Lancet · 2015 · 3.6K citations

Medicine, Geriatric Medicine, Preventive Medicine +17

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

Miia Kivipelto, Tiia Ngandu, Tiina Laatikainen et al. · The Lancet Neurology · 2006 · 1.1K citations

Medicine, Geriatric Medicine, Neurology +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

Ruth Peters, Nigel Beckett, Françoise Forette et al. · The Lancet Neurology · 2008 · 773 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13